Dermacyd Tina Gel Sweet Flower - Photo Evaluation

Sanofi

Status and phase: Completed; Phase 3

Conditions: Healthy

Treatments: Drug: Lactic acid (Dermacid)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00668629

LACAC_L_03734

Details and patient eligibility

About

The purpose of this study is to prove the absence of photo irritation and photo sensitivity potential of the product Dermacyd Tina Gel Sweet Flower.

Enrollment: 25 patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Phototype Skin II and III
• Integral skin test in the region

Exclusion criteria

• Lactation or gestation
• Use of Antiinflammatory and/or immunosuppression drugs 15 days before the selection
• Diseases which can cause immunity decrease, such as HIV, diabetes
• Use of drug photosensitizer
• History of sensitivity or irritation for topic products
• Active cutaneous disease which can change the study results
• History or photodermatosis active
• Family or personal antecedent of cutaneous photoinduced neoplasias
• Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium
• Intense solar exposure in the study area
• Use of new drugs or cosmetics during the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)